key: cord-0807953-elwhzp9u
authors: Liu, Pin; Zheng, Junwen; Yang, Pu; Wang, Xia; Wei, Cong; Zhang, Shiyu; Feng, Shuwen; Lan, Jing; He, Bingyan; Zhao, Dongchi; Li, Jiafu; Zhang, Yuanzhen
title: The immunologic status of newborns born to SARS-CoV2-infected mothers in Wuhan, China
date: 2020-05-11
journal: J Allergy Clin Immunol
DOI: 10.1016/j.jaci.2020.04.038
sha: 226ac3fa4cac1afa243b55755141ba246e8ea68a
doc_id: 807953
cord_uid: elwhzp9u

Background Immunologic dysfunction due to COVID-19 is closely related to clinical prognosis, and the inflammatory response of pregnant women may affect the directional differentiation and function of fetal immune cells. Objective To analyze the immune status of newborns from mothers with COVID-19 in the third trimester. Methods Along with collecting the clinical data from 51 newborns and their respective mothers, we also recorded the immunophenotypes and cytokine and immunoglobulin levels of the newborns. Results None of the 51 newborns showed fever or respiratory distress during hospitalization. Detection of SARS-CoV-2 nucleic acid in pharyngeal swabs was negative. Except for the low level of CD16-CD56 cells, the count and proportion of lymphocytes, CD3, CD4, CD8, and CD19 were all in the normal range. Moreover, the serum IgG and IgM levels were within the normal range, while IL-6 showed increased levels. There was no correlation between maternal COVID-19 duration and the lymphocyte subsets or cytokine levels (IFN-γ, IL-2, IL-4, IL-6, IL-10 and TNF-α). There was a positive correlation between IL-6 and IL-10 levels and CD16-CD56 cells. One (1.96%) infant with an extremely elevated IL-6 concentration developed necrotizing enterocolitis in the third week after birth, and the remaining 50 infants did not show abnormal symptoms through the end of the follow-up period. Conclusion COVID-19 in the third trimester did not significantly affect the cellular and humoral immunity of the fetus, and there was no evidence that the differentiation of lymphocyte subsets was seriously unbalanced.

X Wang, C Wei, S Zhang, S Feng, J Lan and B He recruited the patients, collected specimens, collected demographic, clinical, and laboratory data; J Zheng, and P Yang interpreted the laboratory results and the images of CT scans; P Liu, J Zheng, J Li, Y Zhang and D Zhao analyzed the data; and P Liu, J Zheng and D Zhao wrote the initial drafts of the manuscript; All authors read and approved the final report and have no conflicting issues with the contributions listed herein.. 

Humans are generally susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1, 2 , and pregnant women and newborns are at potential risk groups for coronavirus disease 2019 (COVID-19) [3] [4] [5] . As of April 13, there were 1,773,084 people globally that were confirmed infected with SARS-CoV-2 virus in the COVID-19 pandemic, resulting in 111,652 deaths (WHO, COVID-19 daily update).

Coronavirus infection in pregnant women can cause adverse consequences, such as spontaneous miscarriage, preterm delivery, intrauterine growth restriction and stillbirth [6] [7] [8] . Although there is no evidence of mother-to-child vertical transmission of SARS-CoV-2 3, 9 , it is urgent to clarify whether the maternal inflammatory response in the third trimester affects the development and physiological state of newborns.

The incidence of critical illness caused by COVID-19 is near 19% 2, 5, 10 , of which most cases progress to acute respiratory distress syndrome (ARDS) and respiratory failure, accompanied by acute immune dysfunction 10 . SARS-CoV-2 infection causes a sharp decline in lymphocyte counts, especially a reduction in CD4 T cells, accompanied by an uncontrolled release of inflammatory cytokines, leading to the second strike and aggravating pathological changes in the respiratory system 10 . The clinical symptoms vary among the infected population 11, 12 , suggesting that individual immune status is related to COVID-19 susceptibility and that immune dysfunction may play an essential role in developing critical illness.

Due to the special immunologic status of pregnant women, the maternal inflammatory response to coronavirus infection may affect the structural and functional development of the fetus and neonate 6, 13 .

In children, COVID-19 is mild or asymptomatic 12 ; on the other hand, the virus can remain in the body for a long time, and viral nucleic acids can persist in feces, which implies that there is a possibility of nonrespiratory transmission in children 14 . The immaturity of immunologic function in children and newborns leads to their increased susceptibility to viral infections, while the immaturity of adaptive immunologic development may make their clinical symptoms different from those in adults 13 . Together, these aspects raise serious questions as to why clinical manifestations of infected children and newborns are different from those of adults with immunosuppression and what impact the inflammatory reaction caused by maternal infection has on the immunologic function of the fetus.

We speculate that the answers may be related to the immaturity of fetal immunity, especially dominant immune tolerance. Given the critical role of immunologic activity in COVID-19 pathogenesis and the possible influence of infected mothers on the differentiation of immunologic cells in newborns, we analyzed the immunologic status of newborns born to mothers with COVID-19 in the third trimester 15 .

From January 20 to March 3, 2020, 71 newborns born to mothers with COVID-19 were admitted to the neonatal intensive care unit (NICU) isolation ward of Zhongnan Hospital of Wuhan University. The included criterion was newborns whose mother had clinically confirmed or confirmed COVID-19 16 .

The exclusion criteria were premature infants of gestational age (GA) less than 35 weeks (12 cases), newborns with suspected congenital malformations (1 case), and children with incomplete laboratory data (7 cases). Thus, a total of 20 cases were excluded from the total cases enrolled in the study.

Ultimately, 51 cases were eligible for further analysis.

Wuhan, as the epidemic center at the beginning of COVID-19 pandemic, all patients here including the pregnant woman and children who admitted for hospitalization would take chest imaging scans during the epidemic as a supplementary tool for the detection of COVID-19 17 , given the reality that RT-PCR test showed a certain false-negative rate in the diagnosis of COVID-19 18 . Hence, fifty-one pregnant women underwent chest imaging before delivery, with symptoms such as fever, cough, vomiting and running nose or were asymptomatic at a routine prenatal examination in this particular period. All of them showed imaging changes corresponding to viral pneumonia. Among them, 48 women had a cesarean section, and 3 women delivered naturally. All the women were wearing the medical surgical masks during surgery or delivery. The newborns were quickly isolated from the mothers within 10 minutes after delivery, transferred to the NICU negative pressure isolation ward (-10 Pa) and placed in an incubator for observation. Apgar scores at 1 and 5 minutes were recorded, and the first pharyngeal swab was collected within 30 minutes after birth.

Pharyngeal swabs collected on days 0, 1, and 5 after birth were sealed in preservation solution and sent to the P3 laboratory of Zhongnan Hospital. Peripheral blood was collected on the day of birth and analyzed for routine blood tests, blood biochemistry, coagulation assays, and blood culture. Blood samples were collected within 3 days after birth for the detection of immunoglobulin levels, cytokine concentrations, and lymphocyte subsets.

RNA extraction and real-time quantitative RT-PCR were carried out to detect the SARS-CoV-2 nucleic acid according to a 2019 novel coronavirus (ORF1ab/N gene) nucleic acid detection kit (Bio-Germ Medical Technology Co., Ltd., Shanghai, China).When the RT-PCR results of pharyngeal swabs were "suspected to be positive", the three consecutive follow-up pharyngeal swabs (one day apart each time)

were detected. The final result was judged as "false positive", if the three consecutive follow-up pharyngeal swabs tests were negative. Once a positive result appeared, it would be defined as "positive".

The expression of CD3, CD4, CD8, CD19, and CD16-CD56 on cells in peripheral blood cells was Serum immunoglobulin levels of IgA, IgG, IgM, and IgE were determined by nephelometry (Siemens Healthcare Diag Prod GmbH, Marburg, Germany).

All newborns did not require mechanical ventilation during hospitalization, and few of them received low-flow nasal catheter oxygen for less than 3 days. Those with premature rupture of membranes or increased inflammation indicators received empirical antibiotics (piperacillin-tazobactam). Upon the negative blood culture and the rebound in inflammation indicators back to normal, the antibiotics were ceased. All infants were fed formula milk during hospitalization, and none of them received antiviral treatment. The newborns were discharged home for isolation until three consecutive nucleic acid tests were negative. Breastfeeding was recommended when the mother had been isolated for more than 14 days and the SARS-CoV-2 nucleic acid test was negative.

During hospitalization, the general vital signs, feeding, neurological reactions, and laboratory results of the newborns were continuously recorded. The families of the newborns received telephone follow-up of the baby's general condition and abnormal clinical signs after discharge.

All the data are presented as the mean ± SD. Statistical analyses were performed using a two-tailed unpaired t-test, one-way ANOVA or linear regression analyses. A P value < 0.05 was considered significant. All statistical calculations were performed with Prism 8 (GraphPad Software Inc., La Jolla, CA).

The present study was registered as a clinical study with the Chinese Clinical Trial Registry

Among the 51 pregnant women, the average age was 31.94 ± 4.02 years. Seven cases were positive for SARS-CoV-2 nucleic acid, of which 4 cases presented clinical symptoms (fever, cough), the remaining 3 cases were asymptomatic. All mothers underwent chest computerized tomography (CT) examination before admission, and all showed specific signs of COVID-19-induced pneumonia changes (ground-glass opacity, patchy or consolidation). Among them, 37 cases took chest CT scans on the day of or one day before delivery; 14 cases performed 2 to 19 days before delivery. Clinical symptoms were presented in 24 (47.1%) out of 51 cases before delivery. For the disease course, 10 cases (19.6%) had begun within 1 week, 14 cases (27.5%) had begun over 1 week prior, and the longest onset was 28 days before delivery. The postpartum conditions of the women were stable, and no critical illness or death occurred (Table 1) .

A total of 51 neonates (27 female (52.94%) and 24 male (47.06%)) were enrolled, and the median GA was 38 weeks (35 +1 to 41 +2 w), of which 6 (11.76%) were late preterm (≥35 w and <37 w) and 45 (88.24%) were full-term. The median birth weight (BW) was 3080 g (1990 g-3950 g), 47 (92.16%) with a BW above 2500 g. Apgar scores at 1 and 5 minutes were 8.90 and 9.90 points, respectively (Table 1 ).

All newborns were monitored by throat swabs on days 0, 1, and 5 of hospitalization. SARS-CoV-2 nucleic acid results were judged to be "false positive" in 3 of 51 neonates at the first sampling and 3 at the second sampling. One case showed two consecutive false positive results of pharyngeal swab nucleic acid tests after birth (while chest CT examination was normal); however, the three consecutive follow-up examinations of the 5 cases were negative. The remaining 46 cases were negative for 3 consecutive nucleic acid results (Table 1) .

The 51 neonates were monitored by electrocardiograph (ECG) after birth. No fever, cough, or nasal congestion occurred during hospitalization. Ten patients showed a transient sign of abdominal distension or vomiting. A chest imaging test was performed on the day of or the next day after admission, which showed no specific viral pneumonia changes (Supplementary Figure 1a,1b) .

Thirty-one neonates (60.8%) received antibiotics, 20 (39.2%) did not receive antibacterial treatment, and none received antiviral therapy. Except for one case of a GA 35 +5 w neonate who had abdominal distension and bloody stools in the third week after birth and was diagnosed with necrotizing enterocolitis (NEC), the other neonates were in stable condition. The average hospital stay was 8.96 ± 4.96 days.

The routine blood and immune cell characterization within 3 days after birth are shown in Table 2 

Because maternal infection in different stages may affect the immune status of the fetus, we performed correlation analysis between different immune cell subtypes and maternal infection duration. The results showed that as the time from onset to delivery extended, the WBC and CD3, CD4, CD8, CD19, and CD16-CD56 cell counts gradually decreased, but there was no statistical correlation among them (P> 0.05) (Figure 1) . We therefore divided the 51 cases into three groups according to maternal clinical symptoms: the asymptomatic group (None, n = 27), onset to delivery within 1 week group (Within 1 w, n = 10) and onset to delivery over 1 week group (Over 1 w, n = 14). The results showed that there was no statistically significant difference in WBC, ALC, or CD3, CD4 and CD8 numbers among the three groups (P> 0.05) (Figure 2 ), which indicated that the span of maternal prepartum infection did not affect fetal lymphocyte differentiation. Among the three groups, the CD19% and CD19 cell counts of the Within and Over 1 w groups were lower than those of the None group ( Figure 3a) ; the CD16-CD56% and CD16-CD56 cell counts in the Within and Over 1 w groups were slightly lower than those in the None group, but there was no statistical significance (p> 0.05) (Figure 4a ).

The newborn serum immunoglobulin levels were analyzed and showed that IgG levels were similar in the None, Within 1 w and Over 1 w groups and that there was no significant difference among them ( Figure 3b ). IgM content was slightly higher (at an average level of 0.22 ± 0.04 g/L) than the detection threshold (<0.175 g/L) in 10 cases, while in the other 41 cases, the level of IgM was under the detection threshold. The CD19 lymphocyte cell counts in these 10 cases were within the normal range, which suggested that fetal CD19 cells were not activated in the uterus.

The cytokine levels of IFN-γ, IL-2, IL-4, IL-6, IL-10 and TNF-α among the three groups were analyzed ( Figure 4b) . The levels of TNF-α and IL-6 were decreased uniquely in the Within and Over 1 w groups, but there was no significant difference; the levels of IFN-γ, IL-4 and IL-10 were decreased only in the Within 1 w group but showed no significant difference as well. However, IL-6 content correlated positively with IL-10 content and CD16-CD56 cell counts (p <0.05) ( Figure 5 ). In this data set, IL-6 content was not normally distributed, and the mean level (10.82 pg/ml) was higher than the reference range (0.1-2.9 pg/ml). Since IL-6 and IL-10 have promoting/tolerance effects in the inflammation process to control the usual inflammatory response, the imbalance between the two may lead to variable inflammation or immunosuppression, 13 we speculated that the imbalance between the two cytokines may lead to excessive inflammation or immunosuppression.

For further study, we divided the patients into four groups: the IL-6 normal group (0.1-2.9 pg/ml, n = showed that there were no significant differences in the newborns' sex, GA, BW, positive rate of viral nucleic acid tests, chest imaging results, incidence of abnormal symptoms, or maternal COVID-19 progression clinical features (Table 3 ). However, one newborn (GA of 35 +5 weeks, BW of 2.26 kg) was generally in good condition at birth and had no difficulty feeding, but her IL-6 level was the highest among the 51 neonates, with a value as high as 109.42 pg/ml, and her procalcitonin level was slightly augmented, reaching a maximum level of 6.74 ng/ml. Twenty-two days after birth, severe NEC occurred.

In this paper, we have discussed the immunological characteristics of 51 neonates with a risk of intrauterine exposure to SARS-CoV-2 in the COVID-19 pandemic from Wuhan, China. With the strictly protective measures, none of the 51 newborns suffered from COVID-19.

Our study is unique in demonstrating that intrauterine exposure poses no serious threat to the development of cellular and humoral immune function in near-term and full-term infants. However, the biased expression of inflammatory factors may be an important indicator of complications. To the best of our knowledge, this study is the first comprehensive and large-scale assessment report on the immune status of this population. The results from this study may further help us understand the immune function of newborns delivered by mothers infected with SARS-CoV-2 and improve treatment and prevention strategies 6, 7, 20 . Although no evidence of vertical transmission of SARS-CoV-2 from mother to child has been found 3, 4, 21 , the potential effects of the maternal inflammatory response on development and immunologic function in exposed neonates are unknown 20, 22 . As the epidemic situation in China has gradually been controlled, a spreading trend was focused in Europe and the Middle East 23 . Elderly individuals and those with underlying diseases are at high risk of developing critical illness or even dying 2 . Newborns and children who are immunocompromised or immune immature suffer relatively few infections, accounting for approximately 2.0% of the total cases confirmed, and have a low rate of severe and critical illness 5, 24 . The incidence of COVID-19 in pregnant women or the proportion of the entire infected population has not yet been reported, but according to epidemiological data of SARS and MERS, maternal mortality rates are as high as 25% and 23% 6, 7 . Coronavirus infection in pregnant women can cause severe complications and multiple organ damage in newborns 25, 26 .

One patient developed abdominal distension and bloody stools and rapidly developed NEC in the third week after birth. Her blood and stool cultures and rotavirus and enterovirus detection were all negative, which is very similar to the two cases of neonatal intestinal perforation reported during the SARS epidemic 25 . Five cases of SARS-CoV-2 nucleic acid tests were judged to be "false positive" the first or second time;and none of the 5 newborns developed clinical manifestations, such as fever, respiratory abnormalities, and gastrointestinal symptoms. We speculate that this "false positive" is not caused by vertical transmission but may be related to the detection sensitivity of reagents or the presence of trace virus or sample contamination in the environment.

Due to the role of the placental barrier, the newborn is in a relatively closed environment in the uterus 27 .

CD4 + CD25 + Foxp3 regulatory T cells (Treg cells) play a dominant role in the formation of immune tolerance with the mother 15, 27, 28 . After the birth of the newborn, immune cells are stimulated by external antigens, thus affecting their later directional differentiation. This feature may lead to atypical symptoms when neonatal infections occur, but pathogenic microorganisms tend to spread easily 29, 30 .

The absolute value of each lymphocyte subgroup in these neonates was in the normal range, and T cells, CD19 cells and CD16-CD56 cells were positively correlated with lymphocyte counts. This result indicates that COVID-19 mothers did not affect the differentiation of fetal lymphocytes. Serum IgM levels in most of the cases were not increased; only in 10 (19.61%) cases did IgM levels increase slightly, suggesting that the fetus may not be at risk of virus exposure or infection in utero 15, 31 .

In this group of data, with the exception of IL-6 and IL-10, there was no abnormal increase in other cytokines in newborns. In the first week after birth, a large amount of IL-6 can be produced after infection in neonates, increasing the resistance to infection and aiding healing of damaged tissues at birth 32 . Studies have shown that Treg cells expressing IL-10 exert immune tolerance and control the intensity of the inflammatory response. IL-6 promotes Th2 and Th17 cell differentiation, participating in systemic inflammation and autoimmune responses 31 . IL-10 and IL-6 maintain the balance of a moderate inflammatory response and prevent the IL-6-mediated excessive amplified Th17 inflammatory response from becoming uncontrolled 30 .

In our study, the reason for a nondecreased level of IL-10 in newborns may be the continued existence of fetal immune tolerance after birth. The elevated level of IL-6 was positively correlated with that of IL-10, suggesting that fetal immune tolerance was not affected by maternal SARS-CoV-2 infection. In the case of the newborn with NEC, IL-6 content was as high as 109.26 pg/ml (38-fold increase), and the IL-6/IL-10 ratio was 28.8, which was 9.5 times higher than the average level of 3.0. This result implied that the abnormal increase in IL-6 levels without IL-10 regulation might have been an essential indicator of complications. Since there was only one case in the study, a further study is needed to clarify the clinical implication of IL-6/IL-10.

There are limitations to the study. First, a healthy control group could not be set for ethical reasons.

Second, the follow-up time was limited. Although the newborns were monitored for immune function at birth, dynamic changes in the indexes were not detected afterward. Moreover, the types of immune cell subtypes and cytokines were limited, and further interpretation of lymphocyte function has not yet been made.

In summary, our results showed that the mother's infection had no significant effect on the cellular and humoral immunologic status of the newborn and that lymphocyte differentiation was not seriously unbalanced. However, we should pay attention to the relationship between the abnormal elevation of IL-6 levels and serious complications. 

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Corona Virus Disease 2019, a growing threat to children?

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections

Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know

Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

Clinical characteristics and risk assessment of newborns born to mothers with COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Emergence of a novel human coronavirus threatening human health

COVID-19 in Children: Initial Characterization of the Pediatric Disease

Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

Stereotypic Immune System Development in Newborn Children

Diagnosis and Treatment of COVID-19

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence

Reference intervals for lymphocyte subsets in preterm and term neonates without immune defects

From the frontlines of COVID-19 -How prepared are we as obstetricians: a commentary

Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy

Coronavirus infections and immune responses

Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2)

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics

Infants born to mothers with severe acute respiratory syndrome

A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load

Immunology of the Fetus and Newborn: Avery's Diseases of the Newborn: Tenth Edition

Influenza virus-specific CD4+

CD8+ T cell-mediated immunity induced by infection and vaccination

Infant Immune Response to Respiratory Viral Infections

Unbalanced Neonatal CD4(+) T-Cell Immunity

Innate immunity of the newborn: basic mechanisms and clinical correlates

Table 2. Laboratory results of white blood cell count, lymphocyte subsets and cytokines in 51 newborns

CD3 T cells 2442

CD4 T cells 1852

CD16-CD56 as % of ALC

WBC, white blood cell

The opinions expressed reflect the collective views of the co-authors. We thanks Dr. Nitin Saksena, Head of Epigenes, Melbourne, Australia, for editing the manuscript.

Chest radiographs were performed on the day or the next day of admission, which showed no pneumonia changes. a, showed the chest CT examination of one case with a two consecutive suspected positive result of pharyngeal swab nucleic acid after birth. b, showed the chest X-ray picture of neonate born to SARS-CoV-2 infected mother.